← Back to Biocon Ltd. overview
Biocon Ltd. — 10-Year Financials
Annual P&L, balance sheet, and key ratios from public BSE/NSE filings.
| Period | Revenue | Net Profit | EPS (₹) | Total Assets | Shareholder Equity | ROE (%) | ROCE (%) | D/E | Net Margin (%) |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | ₹15,052 cr | ₹1,013 cr | ₹8.46 | ₹58,797 cr | ₹21,644 cr | 4.68% | 6.93% | 0.85x | 6.73% |
| FY2024 | ₹14,196 cr | ₹1,023 cr | ₹8.54 | ₹56,071 cr | ₹19,784 cr | 5.17% | 6.93% | 0.82x | 7.2% |
| FY2023 | ₹10,934 cr | ₹463 cr | ₹3.87 | ₹52,043 cr | ₹17,867 cr | 2.59% | 3.67% | 1.01x | 4.23% |
| FY2022 | ₹8,025 cr | ₹648 cr | ₹5.42 | ₹20,394 cr | ₹8,433 cr | 7.69% | 7.74% | 0.61x | 8.08% |
Revenue: Total income from operations (₹ crore).
EPS: Earnings per share (₹), basic.
ROE: Net profit / average shareholder equity.
ROCE: EBIT / capital employed.
D/E: Total debt / shareholder equity.
Net Margin: Net profit as a % of revenue.
All figures sourced from public BSE/NSE filings. Ratios are pre-computed estimates and may differ from primary filings due to rounding.
Educational content — not investment adviceAll financial data is sourced from public filings and shown here for educational purposes only. EquitiesIndia.com is not a SEBI-registered Investment Adviser or Research Analyst. Nothing on this page constitutes a recommendation or solicitation to transact in any security. All data is at least 90 days old. Past performance is not indicative of future results.